MRNA

Moderna

Health Care

Biotechnology

Cambridge, Massachusetts

Balance Sheet 38 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$1.9B	$2.9B	$3.2B	$6.8B	$2.6B
Assets - MarketableSecuritiesCurrent	$5.1B	$5.7B	$6.7B	$3.9B	$2.0B
Assets - AccountsReceivable	$358.0M	$892.0M	$1.4B	$3.2B	$1.4B
Assets - Inventories	$117.0M	$202.0M	$949.0M	$1.4B	$47.0M
Assets - PrepaidExpensesAndOtherCurrentAssets	$599.0M	$627.0M	$1.2B	$728.0M	$252.0M
Assets - TotalCurrentAssets	$8.1B	$10.3B	$13.4B	$16.1B	$6.3B
Assets - Property,PlantAndEquipment	$2.2B	$1.9B	$2.0B	$1.2B	$297.0M
Assets - Goodwill	$52.0M	$52.0M	$0	—	—
Assets - IntangibleAssets(net,ExcludingGoodwill)	$40.0M	$44.0M	$0	—	—
Assets - MarketableSecuritiesNoncurrent	$2.5B	$4.7B	$8.3B	$6.8B	$639.0M
Assets - DeferredTaxAssets	$277.0M	$454.0M	$1.2B	$526.0M	$51.0M
Assets - OperatingLeaseAssets	$759.0M	$713.0M	$121.0M	$142.0M	$90.0M
Assets - FinanceLeaseAssets	$65.0M	$436.0M	$1.1B	$665.0M	$55.0M
Assets - OtherNoncurrentAssets	$594.0M	$766.0M	$988.0M	$46.0M	$2.0M
Assets - TotalAssets	$14.1B	$18.4B	$25.9B	$24.7B	$7.3B
Liabilities - AccountsPayable	$405.0M	$520.0M	$487.0M	$302.0M	$18.0M
Liabilities - AccruedLiabilities	$1.4B	$1.8B	$2.1B	$1.5B	$470.0M
Liabilities - ContractLiabilitiesCurrent	$153.0M	$568.0M	$2.0B	$6.3B	$3.9B
Liabilities - OperatingLeaseLiabilitiesCurrent	$14.0M	$25.0M	$35.0M	$46.0M	$6.0M
Liabilities - FinanceLeaseLiabilitiesCurrent	$23.0M	$0	$161.0M	$165.0M	$24.0M
Liabilities - OtherCurrentLiabilities	$221.0M	$129.0M	$249.0M	$225.0M	$34.0M
Liabilities - TotalCurrentLiabilities	$2.2B	$3.0B	$4.9B	$9.1B	$4.4B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$671.0M	$643.0M	$92.0M	$106.0M	$97.0M
Liabilities - FinanceLeaseLiabilitiesNoncurrent	$39.0M	$575.0M	$912.0M	$599.0M	$110.0M
Liabilities - DeferredTaxLiabilitiesNoncurrent	$71.0M	$122.0M	$86.0M	$50.0M	$19.0M
Liabilities - OtherNoncurrentLiabilities	$267.0M	$256.0M	$135.0M	$76.0M	$3.0M
Liabilities - TotalLiabilities	$3.2B	$4.6B	$6.7B	$10.5B	$4.8B
Equity - PreferredStock	$0	$0	$0	$0	$0
Equity - CommonStock	$0	$0	$0	$0	$0
Equity - AdditionalPaidInCapital	$866.0M	$371.0M	$1.2B	$4.2B	$4.8B
Equity - RetainedEarnings(deficit)	$10.0B	$13.6B	$18.3B	$10.0B	$-2.2B
Equity - TreasuryStock	$0	$8.0M	$23.0M	$3.0M	—
Equity - AccumulatedOtherComprehensiveIncome(loss)	$-10.0M	$-123.0M	$-370.0M	$-24.0M	$3.0M
Equity - TotalStockholdersEquity	$10.9B	$13.9B	$19.1B	$14.1B	$2.6B
Equity - TotalLiabilitiesAndStockholdersEquity	$14.1B	$18.4B	$25.9B	$24.7B	$7.3B
Equity - TotalLiabilitiesandEquity	$14.1B	$18.4B	$25.9B	$24.7B	$7.3B
Validation - L+E Components Sum Difference	$0	$0	$0	$0	$0

Income Statement 20 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetRevenues/ProductSales	$3.2B	$6.8B	$19.3B	$18.5B	$803.0M
IncomeStatement - CostsAndExpenses - CostOfGoodsSold/CostOfSales	$1.5B	$4.7B	$5.4B	$2.6B	$8.0M
IncomeStatement - CostsAndExpenses - ResearchAndDevelopmentExpense	$4.5B	$4.8B	$3.3B	$2.0B	$1.4B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative	$146.0M	$204.0M	$121.0M	$0	—
IncomeStatement - CostsAndExpenses - ImpairmentCharges(operating)	$0	$0	$0	$0	$0
IncomeStatement - OtherIncomeExpense - OperatingIncome(loss)	$-3.9B	$-4.2B	$9.4B	$13.3B	$-763.0M
IncomeStatement - OtherIncomeExpense - InterestExpense	$24.0M	$38.0M	$29.0M	$17.0M	$10.0M
IncomeStatement - OtherIncomeExpense - InterestIncome	$425.0M	$421.0M	$200.0M	$18.0M	$25.0M
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$-87.0M	$-124.0M	$-45.0M	$-29.0M	$-6.0M
IncomeStatement - OtherIncomeExpense - Income(loss)BeforeIncomeTaxes	$-3.6B	$-3.9B	$9.6B	$13.3B	$-744.0M
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$-46.0M	$772.0M	$1.2B	$1.1B	$3.0M
IncomeStatement - IncomeTax - EffectiveTaxRate	$0	$-0	$0	$0	$-0
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$-3.6B	$-4.7B	$8.4B	$12.2B	$-747.0M
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$-3.6B	$-4.7B	$8.4B	$12.2B	$-747.0M
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$-9	$-12	$21	$30	$-2
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$-9	$-12	$20	$28	$-2
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$384.0M	$382.0M	$394.0M	$403.0M	$381.0M
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$384.0M	$382.0M	$416.0M	$431.0M	$381.0M
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$-3.4B	$-4.5B	$8.0B	$12.2B	$-746.0M

Cash Flow Statement 21 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - NetIncome	$-3.6B	$-4.7B	$8.4B	$12.2B	$-747.0M
CashFlow - OperatingActivities - DepreciationAndAmortization	$185.0M	$617.0M	$348.0M	$232.0M	$31.0M
CashFlow - OperatingActivities - ShareBasedCompensation	$429.0M	$305.0M	$226.0M	$142.0M	$93.0M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-1.0M	$901.0M	$-578.0M	$-296.0M	$0
CashFlow - OperatingActivities - ImpairmentCharges(nonCash)	$0	$0	$0	$0	$0
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$-1.6B	$-5.3B	$-4.9B	$8.7B	$5.9B
CashFlow - OperatingActivities - NetCashFromOperatingActivities	$-3.0B	$-3.1B	$5.0B	$13.6B	$2.0B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e)	$1.1B	$707.0M	$400.0M	$284.0M	$68.0M
CashFlow - InvestingActivities - PurchasesOfMarketableSecurities/investments	$6.5B	$3.8B	$11.4B	$12.7B	$3.0B
CashFlow - InvestingActivities - ProceedsFromSales/maturitiesOfMarketableSecurities/investments	$4.0B	$3.2B	$3.5B	$3.1B	$215.0M
CashFlow - InvestingActivities - AcquisitionsOfBusinesses,NetOfCash	$0	$85.0M	$0	$0	—
CashFlow - InvestingActivities - PaymentsToAcquireIntangibleAssets	$155.0M	$301.0M	$1.1B	$641.0M	$7.0M
CashFlow - InvestingActivities - NetCashFromInvestingActivities	$1.9B	$4.2B	$-5.2B	$-8.5B	$-1.7B
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$0	$1.2B	$3.3B	$857.0M	$0
CashFlow - FinancingActivities - ProceedsFromIssuanceOfCommonStock	$42.0M	$25.0M	$0	$0	$1.9B
CashFlow - FinancingActivities - NetCashFromFinancingActivities	$56.0M	$-1.4B	$-3.4B	$-873.0M	$2.0B
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$-999.0M	$-289.0M	$-3.6B	$4.2B	$2.4B
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$197.0M	$-357.0M	$2.7B	$480.0M	$1.0M
CashFlow - CashReconciliationAndSupplemental - InterestPaid	$24.0M	$39.0M	$25.0M	$14.0M	$9.0M
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$100.0M	$714.0M	$20.0M	$72.0M	$17.0M

Moderna

Balance Sheet 38 Accounts • 5 Years

Income Statement 20 Accounts • 5 Years

Cash Flow Statement 21 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History